Author： Norman Peter
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.10, 2012-10, pp. : 1257-1261
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
This application claims processes for the preparation of a series of pyrrole-based DP2 receptor antagonists, in particular 2-[3-cyano-2,5-dimethyl-4-[(2-pyrrolidin-1-ylsulfonylphenyl)methyl]pyrrol-1-yl]acetic acid. The nature of the filing points to this compound being a development compound and it may be IW-1221 which has previously been identified as a DP2 antagonist.
Related content
Access to resources
Recommend
DP2 receptor antagonists in development
By Norman Peter
Expert Opinion on Investigational Drugs, Vol. 19, Iss. 8, 2010-08 ,pp. :
By Angiolillo Dominick J Suryadevara Siva Capranzano Piera Bass Theodore A
Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. :